2

Why a Mission, Vision and Strategy statement?

Year:
2010
Language:
english
File:
PDF, 46 KB
english, 2010
13

Myofascial release: an evidence-based treatment approach?

Year:
2008
Language:
english
File:
PDF, 398 KB
english, 2008
17

Chlorprothixene (“Truxal”) compared to chlorpromazine

Year:
1961
Language:
english
File:
PDF, 310 KB
english, 1961
18

Interleukin 1 Activity in the Acquired Immunodeficiency Syndrome

Year:
1986
Language:
english
File:
PDF, 2.11 MB
english, 1986
20

Phorbol Myristate Acetate -Fate and Usability in a Human Interleukin-1 Assay

Year:
1985
Language:
english
File:
PDF, 5.34 MB
english, 1985
25

Treatment of Wegener's granulomatosis with trimethoprim-sulfamethoxazole

Year:
1990
Language:
english
File:
PDF, 133 KB
english, 1990
28

THE INDIRECT LEUCOCYTE MIGRATION INHIBITION ASSAY — AN ENDOTOXIN-SENSITIVE CHEMOKINETIC ASSAY. PART II

Year:
1986
Language:
english
File:
PDF, 420 KB
english, 1986
29

Dialysis membrane interference in human T-lymphocyte proliferation assays

Year:
1989
Language:
english
File:
PDF, 492 KB
english, 1989
34

CON A INDUCED SUPPRESSOR TEST AN EVALUATION OF THE EXPERIMENTAL CONDITIONS

Year:
1982
Language:
english
File:
PDF, 401 KB
english, 1982
36

Estimation of variability in the assay of human interleukin-1

Year:
1986
Language:
english
File:
PDF, 581 KB
english, 1986